Drugmakers slash prices to be eligible for China's bulk-buy program
Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest bidding round under China's national bulk-buy program, government officials said late on Friday. [Source]
Publication Date:Origin: reuters.com
Category: companyNews
Topics: program, bulk-buy, prices, said late, officials, government, national, under China's, round, bidding, latest, products, off-patent, of their, average, chopped, drugmakers, and generic, majors, pharmaceutical, Global, China's, eligible, slash, Drugmakers